2,5-bis(4-methylphenyl)-1,3,4-oxadiazole;bis(2,3-dihydroquinoxaline);ethane;bis((3Z)-hexa-1,3,5-triene);2-methyl-5-(4-methylphenyl)-1,3,4-oxadiazole;2-methyl-5-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;pyrazine;pyridazine;pyridine;pyrimidine;quinoline;quinoxaline

C174H304N22O4 — CID 158477968

IUPAC2,5-bis(4-methylphenyl)-1,3,4-oxadiazole;bis(2,3-dihydroquinoxaline);ethane;bis((3Z)-hexa-1,3,5-triene);2-methyl-5-(4-methylphenyl)-1,3,4-oxadiazole;2-methyl-5-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;pyrazine;pyridazine;pyridine;pyrimidine;quinoline;quinoxaline
SMILESC=C/C=C\C=C.C=C/C=C\C=C.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.Cc1ccc(-c2nnc(-c3ccc(-c4nnc(C)o4)cc3)o2)cc1.Cc1ccc(-c2nnc(-c3ccc(C)cc3)o2)cc1.Cc1ccc(-c2nnc(C)o2)cc1.c1ccc2c(c1)=NCCN=2.c1ccc2c(c1)=NCCN=2.c1ccc2ncccc2c1.c1ccc2nccnc2c1.c1ccncc1.c1ccnnc1.c1cnccn1.c1cncnc1
InChIInChI=1S/C18H14N4O2.C16H14N2O.C10H10N2O.C9H7N.2C8H8N2.C8H6N2.2C6H8.C5H5N.3C4H4N2.34C2H6/c1-11-3-5-13(6-4-11)17-21-22-18(24-17)15-9-7-14(8-10-15)16-20-19-12(2)23-16;1-11-3-7-13(8-4-11)15-17-18-16(19-15)14-9-5-12(2)6-10-14;1-7-3-5-9(6-4-7)10-12-11-8(2)13-10;1-2-6-9-8(4-1)5-3-7-10-9;3*1-2-4-8-7(3-1)9-5-6-10-8;2*1-3-5-6-4-2;1-2-4-6-5-3-1;1-2-6-4-3-5-1;1-2-5-4-6-3-1;1-2-4-6-5-3-1;34*1-2/h3-10H,1-2H3;3-10H,1-2H3;3-6H,1-2H3;1-7H;2*1-4H,5-6H2;1-6H;2*3-6H,1-2H2;1-5H;3*1-4H;34*1-2H3/b;;;;;;;2*6-5-;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
InChIKeyHHEAKGVQJXECBP-UDTOWKIMSA-N
MW2768.50 g/mol
LogP55.42
Rot. Bonds10

About 2,5-bis(4-methylphenyl)-1,3,4-oxadiazole;bis(2,3-dihydroquinoxaline);ethane;bis((3Z)-hexa-1,3,5-triene);2-methyl-5-(4-methylphenyl)-1,3,4-oxadiazole;2-methyl-5-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;pyrazine;pyridazine;pyridine;pyrimidine;quinoline;quinoxaline

2,5-bis(4-methylphenyl)-1,3,4-oxadiazole;bis(2,3-dihydroquinoxaline);ethane;bis((3Z)-hexa-1,3,5-triene);2-methyl-5-(4-methylphenyl)-1,3,4-oxadiazole;2-methyl-5-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;pyrazine;pyridazine;pyridine;pyrimidine;quinoline;quinoxaline (PubChem CID 158477968) has the molecular formula C174H304N22O4 and a molecular weight of 2768.50 g/mol. Its IUPAC name is 2,5-bis(4-methylphenyl)-1,3,4-oxadiazole;bis(2,3-dihydroquinoxaline);ethane;bis((3Z)-hexa-1,3,5-triene);2-methyl-5-(4-methylphenyl)-1,3,4-oxadiazole;2-methyl-5-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;pyrazine;pyridazine;pyridine;pyrimidine;quinoline;quinoxaline.

Molecular Properties

Compound Name2,5-bis(4-methylphenyl)-1,3,4-oxadiazole;bis(2,3-dihydroquinoxaline);ethane;bis((3Z)-hexa-1,3,5-triene);2-methyl-5-(4-methylphenyl)-1,3,4-oxadiazole;2-methyl-5-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;pyrazine;pyridazine;pyridine;pyrimidine;quinoline;quinoxaline
PubChem CID158477968
Molecular FormulaC174H304N22O4
Molecular Weight2768.50 g/mol
Exact Mass2766.43
IUPAC Name2,5-bis(4-methylphenyl)-1,3,4-oxadiazole;bis(2,3-dihydroquinoxaline);ethane;bis((3Z)-hexa-1,3,5-triene);2-methyl-5-(4-methylphenyl)-1,3,4-oxadiazole;2-methyl-5-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;pyrazine;pyridazine;pyridine;pyrimidine;quinoline;quinoxaline
SMILESC=C/C=C\C=C.C=C/C=C\C=C.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.Cc1ccc(-c2nnc(-c3ccc(-c4nnc(C)o4)cc3)o2)cc1.Cc1ccc(-c2nnc(-c3ccc(C)cc3)o2)cc1.Cc1ccc(-c2nnc(C)o2)cc1.c1ccc2c(c1)=NCCN=2.c1ccc2c(c1)=NCCN=2.c1ccc2ncccc2c1.c1ccc2nccnc2c1.c1ccncc1.c1ccnnc1.c1cnccn1.c1cncnc1
InChIInChI=1S/C18H14N4O2.C16H14N2O.C10H10N2O.C9H7N.2C8H8N2.C8H6N2.2C6H8.C5H5N.3C4H4N2.34C2H6/c1-11-3-5-13(6-4-11)17-21-22-18(24-17)15-9-7-14(8-10-15)16-20-19-12(2)23-16;1-11-3-7-13(8-4-11)15-17-18-16(19-15)14-9-5-12(2)6-10-14;1-7-3-5-9(6-4-7)10-12-11-8(2)13-10;1-2-6-9-8(4-1)5-3-7-10-9;3*1-2-4-8-7(3-1)9-5-6-10-8;2*1-3-5-6-4-2;1-2-4-6-5-3-1;1-2-6-4-3-5-1;1-2-5-4-6-3-1;1-2-4-6-5-3-1;34*1-2/h3-10H,1-2H3;3-10H,1-2H3;3-6H,1-2H3;1-7H;2*1-4H,5-6H2;1-6H;2*3-6H,1-2H2;1-5H;3*1-4H;34*1-2H3/b;;;;;;;2*6-5-;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
InChIKeyHHEAKGVQJXECBP-UDTOWKIMSA-N
XLogP55.42
TPSA334.02 Ų
H-Bond Donors
H-Bond Acceptors26
Rotatable Bonds10
Heavy Atoms200
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002768.50
LogP ≤ 555.42
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1026

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'polyene', 'substructure': 'N/A'}

Analyze 2,5-bis(4-methylphenyl)-1,3,4-oxadiazole;bis(2,3-dihydroquinoxaline);ethane;bis((3Z)-hexa-1,3,5-triene);2-methyl-5-(4-methylphenyl)-1,3,4-oxadiazole;2-methyl-5-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;pyrazine;pyridazine;pyridine;pyrimidine;quinoline;quinoxaline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2,5-bis(4-methylphenyl)-1,3,4-oxadiazole;bis(2,3-dihydroquinoxaline);ethane;bis((3Z)-hexa-1,3,5-triene);2-methyl-5-(4-methylphenyl)-1,3,4-oxadiazole;2-methyl-5-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;pyrazine;pyridazine;pyridine;pyrimidine;quinoline;quinoxaline?
The IUPAC name of 2,5-bis(4-methylphenyl)-1,3,4-oxadiazole;bis(2,3-dihydroquinoxaline);ethane;bis((3Z)-hexa-1,3,5-triene);2-methyl-5-(4-methylphenyl)-1,3,4-oxadiazole;2-methyl-5-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;pyrazine;pyridazine;pyridine;pyrimidine;quinoline;quinoxaline (CID 158477968) is 2,5-bis(4-methylphenyl)-1,3,4-oxadiazole;bis(2,3-dihydroquinoxaline);ethane;bis((3Z)-hexa-1,3,5-triene);2-methyl-5-(4-methylphenyl)-1,3,4-oxadiazole;2-methyl-5-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;pyrazine;pyridazine;pyridine;pyrimidine;quinoline;quinoxaline.
What is the SMILES notation for 2,5-bis(4-methylphenyl)-1,3,4-oxadiazole;bis(2,3-dihydroquinoxaline);ethane;bis((3Z)-hexa-1,3,5-triene);2-methyl-5-(4-methylphenyl)-1,3,4-oxadiazole;2-methyl-5-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;pyrazine;pyridazine;pyridine;pyrimidine;quinoline;quinoxaline?
The canonical SMILES for 2,5-bis(4-methylphenyl)-1,3,4-oxadiazole;bis(2,3-dihydroquinoxaline);ethane;bis((3Z)-hexa-1,3,5-triene);2-methyl-5-(4-methylphenyl)-1,3,4-oxadiazole;2-methyl-5-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;pyrazine;pyridazine;pyridine;pyrimidine;quinoline;quinoxaline is C=C/C=C\C=C.C=C/C=C\C=C.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.Cc1ccc(-c2nnc(-c3ccc(-c4nnc(C)o4)cc3)o2)cc1.Cc1ccc(-c2nnc(-c3ccc(C)cc3)o2)cc1.Cc1ccc(-c2nnc(C)o2)cc1.c1ccc2c(c1)=NCCN=2.c1ccc2c(c1)=NCCN=2.c1ccc2ncccc2c1.c1ccc2nccnc2c1.c1ccncc1.c1ccnnc1.c1cnccn1.c1cncnc1.
What is the InChIKey of 2,5-bis(4-methylphenyl)-1,3,4-oxadiazole;bis(2,3-dihydroquinoxaline);ethane;bis((3Z)-hexa-1,3,5-triene);2-methyl-5-(4-methylphenyl)-1,3,4-oxadiazole;2-methyl-5-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;pyrazine;pyridazine;pyridine;pyrimidine;quinoline;quinoxaline?
The InChIKey is HHEAKGVQJXECBP-UDTOWKIMSA-N. The full InChI is InChI=1S/C18H14N4O2.C16H14N2O.C10H10N2O.C9H7N.2C8H8N2.C8H6N2.2C6H8.C5H5N.3C4H4N2.34C2H6/c1-11-3-5-13(6-4-11)17-21-22-18(24-17)15-9-7-14(8-10-15)16-20-19-12(2)23-16;1-11-3-7-13(8-4-11)15-17-18-16(19-15)14-9-5-12(2)6-10-14;1-7-3-5-9(6-4-7)10-12-11-8(2)13-10;1-2-6-9-8(4-1)5-3-7-10-9;3*1-2-4-8-7(3-1)9-5-6-10-8;2*1-3-5-6-4-2;1-2-4-6-5-3-1;1-2-6-4-3-5-1;1-2-5-4-6-3-1;1-2-4-6-5-3-1;34*1-2/h3-10H,1-2H3;3-10H,1-2H3;3-6H,1-2H3;1-7H;2*1-4H,5-6H2;1-6H;2*3-6H,1-2H2;1-5H;3*1-4H;34*1-2H3/b;;;;;;;2*6-5-;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;.
What are the key properties of 2,5-bis(4-methylphenyl)-1,3,4-oxadiazole;bis(2,3-dihydroquinoxaline);ethane;bis((3Z)-hexa-1,3,5-triene);2-methyl-5-(4-methylphenyl)-1,3,4-oxadiazole;2-methyl-5-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;pyrazine;pyridazine;pyridine;pyrimidine;quinoline;quinoxaline?
2,5-bis(4-methylphenyl)-1,3,4-oxadiazole;bis(2,3-dihydroquinoxaline);ethane;bis((3Z)-hexa-1,3,5-triene);2-methyl-5-(4-methylphenyl)-1,3,4-oxadiazole;2-methyl-5-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;pyrazine;pyridazine;pyridine;pyrimidine;quinoline;quinoxaline has a molecular weight of 2768.50 g/mol, XLogP of 55.42, 10 rotatable bonds, 0 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for 2,5-bis(4-methylphenyl)-1,3,4-oxadiazole;bis(2,3-dihydroquinoxaline);ethane;bis((3Z)-hexa-1,3,5-triene);2-methyl-5-(4-methylphenyl)-1,3,4-oxadiazole;2-methyl-5-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;pyrazine;pyridazine;pyridine;pyrimidine;quinoline;quinoxaline is sourced from PubChem (CID 158477968), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).